secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardian Pharmacy Services, Inc. (GRDN)
CIK:        0001802255
Form:       8-K
Filed at:   2025-03-03T23:59:59+00:00
Accession:  0001193125-25-043339
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Guardian Pharmacy reports preliminary Q4 revenue up 20.5% YoY, adj EBITDA up 30.3%; provides FY2025 guidance
--------------------------------------------------------------------------------

- Q4 2024 revenue ~$338.6M, +20.5% YoY; net income $10.1-11.1M; adjusted EBITDA ~$25.9M, +30.3% YoY.
- FY2024 revenue ~$1.228B (+17.4% YoY); adjusted EBITDA ~$90.8M (+19.2% YoY); net loss ($71.8M-$72.8M) due to $131.5M IPO-related share-based comp.
- FY2025 guidance: revenue $1.33-1.35B, adjusted EBITDA $97-101M; conference call March 26, 2025.
- Resident count ~186,000 at Q4 end, +14.1% YoY from organic growth and acquisitions.
- Acquisitions of Heartland Pharmacy (Apr 2024) and Freedom Pharmacy (Nov 2024) contributed to growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802255/000119312525043339/0001193125-25-043339-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802255/000119312525043339/d885796d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-043339

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer